Holistic Integrative Medicine Declaration

doi:10.12114/j.issn.1007-9572.2024.A0021

Abstract

Abstract:

Holistic integrative medicine, abbreviated as HIM, has been officially proposed since 2012. Its theoretical system has been continuously improved, and its practical methods have become increasingly diverse, becoming an inevitable choice and path for the medical development in the new era. This article demonstrates ten major propositions for HIM, elaborating on the connotation and extension of HIM from the perspectives of epistemology and methodology, in order to achieve the transformation and adaptive evolution of modern medicine.

Key words: Wholistic medicine, Holistic integrative medicine, HIM, Medical development

摘要：

整体整合医学（简称整合医学）自2012年被正式提出，其理论体系不断完善，实践方法日趋丰富，成为医学发展新时代的必然选择和必由之路。本文提出整合医学的十大主张，从认识论和方法学上阐述了整合医学的内涵和外延，以期实现现代医学的升维转型和自适应进化。

关键词: 整体医学, 整体整合医学, 整合医学, 医学发展

CLC Number:

R-05

China Institute for Development Strategy of Holistic Integrative Medicine. Holistic Integrative Medicine Declaration[J]. Chinese General Practice, 2024, 27(31): 0-C3. DOI: 10.12114/j.issn.1007-9572.2024.A0021.
中国整合医学发展战略研究院. 整合医学宣言[J]. 中国全科医学, 2024, 27(31): 0-C3. DOI: 10.12114/j.issn.1007-9572.2024.A0021.

[1]	樊代明. 整合医学初探[J]. 医学争鸣，2012，3(2):3-12. DOI：10.13276/j.issn.1674-8913.2012.02.003.
[2]	樊代明. 整合医学——从医学知识到医学知识论[J]. 医学争鸣，2021，12(6):1-11. DOI：10.13276/j.issn.1674-8913.2021.06.001.
[3]	樊代明. 试论医学的正确实践（一）——自然力与医学干预[J]. 医学争鸣，2020，11(1):1-6. DOI：10.13276/j.issn.1674-8913.2020.01.001.
[4]	樊代明. 医学的反向研究[J]. 医学争鸣，2018，9(6):1-4. DOI：10.13276/j.issn.1674-8913.2018.06.001.
[5]	樊代明. 医学的真善美[J]. 中国医学伦理学，2017，30(7):795-796.
[6]	中共中央办公厅　国务院办公厅印发《关于进一步完善医疗卫生服务体系的意见》[A/OL].(2023-03-23)[2024-06-22].
[7]	樊代明. 整合医学——医学发展新时代[J]. 中华医学杂志，2016，96(22):1713-1718. DOI：10.3760/cma.j.issn.0376-2491.2016.22.001.

[1]	ZHAN Li, HENG Zhaoyang, HE Liangyu, ZHAO Jie, CHEN Jie, XING Jinshan. Efficacy and Safety of CAR-T Therapy Targeting the B Cell Maturation Antigen on Relapsed/Refractory Multiple Myeloma in Chinese People: a Meta-analysis [J]. Chinese General Practice, 2026, 29(14): 1921-1930.
[2]	MA Wenyuan, QI Shuo, SHANG Jianwei, CHEN Xiaoheng, LI Zhe, LI Huilong, HU Rui, LI Lu, SI Xinying, DING Zhiguo. Preliminary Development of a TCM Syndrome Evaluation Scale for Hashimoto's Thyroiditis with Normal Thyroid Function: Based on Expert Consultation and Clinical Survey [J]. Chinese General Practice, 2025, 28(28): 3590-3600.
[3]	YI Shengguo, CAO Yedi, ZHAO Xue, LU Guizhi, ZHANG Yang, CONG Tiechuan, ZHANG Lanbo, ZHANG Jixin, LIANG Zhenwei, QU Chenxue, ZHANG Junqing, GAO Ying. EZH2 Expression in B Cell Lymphocyte Subsets of Hashimoto's Thyroiditis and the Therapeutic Mechanism and Effect of Its Inhibitors [J]. Chinese General Practice, 2024, 27(21): 2639-2645.
[4]	GE Yaxue, DING Zhiguo, CHEN Xiaoheng, LI Huilong, QI Shuo, HU Rui. Study on the Distribution of Clinical Symptoms and Syndromes of Hashimoto's Thyroiditis Complicated with Thyrotoxicosis [J]. Chinese General Practice, 2024, 27(21): 2630-2638.
[5]	YU Haibo, ZHANG Tianyu, LI Xin, ZHANG Jiajia, SHEN Man, ZHAN Xiaokai, TANG Ran, FAN Sibin, ZHAO Fengyi, HUANG Zhongxia. Efficacy and Safety of Dual-targeted Chimeric Antigen Receptor-T Cell Therapy in Patients with Refractory-relapsed Multiple Myeloma: a Meta-analysis [J]. Chinese General Practice, 2024, 27(08): 985-994.
[6]	Qian YANG, Hua LU, Qianchen LIU. Characteristics of Metabolic Calorific Values Measured by Infrared Thermal Imaging in Female Adults with Hashimoto's Thyroiditis: an Exploratory Analysis [J]. Chinese General Practice, 2022, 25(18): 2255-2261.
[7]	Huina WAN, Guoyu ZHANG, Hong WAN, Yu FU, Zejin WANG, Shuxun YAN, Ying WANG. Association of Nutritional Factors with Thyroid Autoantibody Titer in Hashimoto's Thyroiditis [J]. Chinese General Practice, 2022, 25(17): 2152-2158.
[8]	WANG Teng，WANG Xiaochen，LYU Chunyi，WANG Jinxin，XU Ruirong. Efficacy and Safety of Chimeric Antigen Receptor T-cell in the Treatment of Multiple Myeloma：a Meta-analysis　 [J]. Chinese General Practice, 2021, 24(2): 219-224.
[9]	MA Jingang，WEI Hongli，SHANG Heng. Factors Associated with Methimazole-induced Leucopenia in Early-phase Treatment of Graves' Disease　 [J]. Chinese General Practice, 2020, 23(35): 4464-4469.
[10]	WU Wenjuan，HU Jintong，TANG Hongxia，ZHANG Xiaoqing，LI Aixia，LI Baoguang，SUN Suzhen. The Clinical Characteristics of Epilepsy Caused by a New Mosaicism Mutation of PCDH19 Gene in a Man were Analyzed and the Literature was Reviewed　 [J]. Chinese General Practice, 2020, 23(29): 3751-3756.
[11]	CHEN Guiying，ZHANG Miaomiao，WU Qunhong. Holistic Integrative Management of Cardiovascular Diseases　 [J]. Chinese General Practice, 2020, 23(11): 1368-1371.
[12]	XIA Wei，ZHANG Chunyan，LI Pengqiu，BAO Mingjing，ZHANG Xuejun，YANG Yan，YANG Yi. Changes in and Factors Influencing 25-hydroxyvitamin D Levels in Pregnant Women with Hashimoto Thyroiditis　 [J]. Chinese General Practice, 2018, 21(36): 4476-4479.
[13]	YING Mei-ke，HAN Ting-ting，WANG Yong-chen，REN Jing-jing. Development Status and Prospect of General Practice and Integrative Medicine　 [J]. Chinese General Practice, 2018, 21(23): 2895-2898.
[14]	DING Jing-ya，QIN Lu-dan，XU Yong*，ZHOU Lu-ping. Use of Antithyroid Drugs in Pregnancy and Lactation——Recent Developments　 [J]. Chinese General Practice, 2018, 21(15): 1869-1873.

Holistic Integrative Medicine Declaration

整合医学宣言

RichHTML

PDF

Knowledge

Abstract

Cite this article

share this article

References 7

Related Articles 14

Recommended Articles

Metrics

Comments